Takahiro SUGIMOTO,Shinkichi SUZUKI,Hiroki SAKAMOTO,Masami YAMADA,Minoru NAKAMURA,Makoto KAMATA,Kenichiro SHIMOKAWA,Takuto KOJIMA
申请号：
US16113635
公开号：
US20180362516A1
申请日:
2018.08.27
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention provides a compound having a cholinergic muscarinic M1 receptor positive allosteric modulator activity, which may be useful as a prophylactic or therapeutic drug for Alzheimer's disease, schizophrenia, pain, sleep disorder, Parkinson's disease dementia, dementia with Lewy bodies and the like. The present invention relates to a compound represented by the formula (I) or a salt thereof:wherein each symbol is as defined in the attached DESCRIPTION.
